Tomomi Hishinuma

1.6k total citations
47 papers, 1.2k citations indexed

About

Tomomi Hishinuma is a scholar working on Molecular Medicine, Molecular Biology and Endocrinology. According to data from OpenAlex, Tomomi Hishinuma has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Medicine, 28 papers in Molecular Biology and 20 papers in Endocrinology. Recurrent topics in Tomomi Hishinuma's work include Antibiotic Resistance in Bacteria (29 papers), Bacterial biofilms and quorum sensing (20 papers) and Antimicrobial Resistance in Staphylococcus (15 papers). Tomomi Hishinuma is often cited by papers focused on Antibiotic Resistance in Bacteria (29 papers), Bacterial biofilms and quorum sensing (20 papers) and Antimicrobial Resistance in Staphylococcus (15 papers). Tomomi Hishinuma collaborates with scholars based in Japan, Nepal and India. Tomomi Hishinuma's co-authors include Keiichi Hiramatsu, Longzhu Cui, Miki Matsuo, Yuki Katayama, Kyoko Kuwahara‐Arai, Tatsuya Tada, Yoshifumi Aiba, Mitsutaka Shoji, Yukiko Watanabe and Hui‐min Neoh and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Tomomi Hishinuma

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomomi Hishinuma Japan 19 710 686 410 300 145 47 1.2k
Shang Wei Wu United States 16 764 1.1× 705 1.0× 250 0.6× 289 1.0× 223 1.5× 23 1.2k
Choon Kim United States 17 488 0.7× 674 1.0× 386 0.9× 129 0.4× 190 1.3× 40 1.1k
Steve N. Leonard United States 11 499 0.7× 458 0.7× 229 0.6× 256 0.9× 134 0.9× 11 937
Zhiwei Lin China 21 319 0.4× 460 0.7× 349 0.9× 175 0.6× 68 0.5× 41 965
Q. C. Truong-Bolduc United States 18 698 1.0× 640 0.9× 507 1.2× 80 0.3× 194 1.3× 29 1.1k
Sandra Rincón Colombia 16 928 1.3× 415 0.6× 249 0.6× 538 1.8× 48 0.3× 35 1.2k
Heidi Gumpert Denmark 14 265 0.4× 356 0.5× 206 0.5× 129 0.4× 205 1.4× 17 742
Anthony J. Yeh United States 15 234 0.3× 373 0.5× 380 0.9× 131 0.4× 51 0.4× 17 870
Emily K. Crispell United States 13 294 0.4× 313 0.5× 193 0.5× 171 0.6× 79 0.5× 17 774
Feng-Jui Chen Taiwan 16 284 0.4× 289 0.4× 228 0.6× 160 0.5× 42 0.3× 36 627

Countries citing papers authored by Tomomi Hishinuma

Since Specialization
Citations

This map shows the geographic impact of Tomomi Hishinuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomomi Hishinuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomomi Hishinuma more than expected).

Fields of papers citing papers by Tomomi Hishinuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomomi Hishinuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomomi Hishinuma. The network helps show where Tomomi Hishinuma may publish in the future.

Co-authorship network of co-authors of Tomomi Hishinuma

This figure shows the co-authorship network connecting the top 25 collaborators of Tomomi Hishinuma. A scholar is included among the top collaborators of Tomomi Hishinuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomomi Hishinuma. Tomomi Hishinuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tohya, Mari, et al.. (2024). Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates from a hospital in Nepal. Journal of Global Antimicrobial Resistance. 38. 363–367. 1 indexed citations
2.
Tohya, Mari, Kanae Teramoto, Tomomi Hishinuma, et al.. (2023). Correction for Tohya et al., “Whole-Genome Sequencing-Based Re-Identification of Pseudomonas putida/ fluorescens Clinical Isolates Identified by Biochemical Bacterial Identification Systems”. Microbiology Spectrum. 11(2). e0430522–e0430522. 2 indexed citations
3.
Ono, Emi, Mari Tohya, Tatsuya Tada, et al.. (2023). Emergence of carbapenem-resistant Pseudomonas alcaligenes and Pseudomonas paralcaligenes clinical isolates with plasmids harbouring bla IMP-1 in Japan. Journal of Medical Microbiology. 72(3). 3 indexed citations
4.
Morimoto, Yuh, Yoshifumi Aiba, Kazuhiko Miyanaga, et al.. (2023). CID12261165, a flavonoid compound as antibacterial agents against quinolone-resistant Staphylococcus aureus. Scientific Reports. 13(1). 1725–1725. 22 indexed citations
5.
Hishinuma, Tomomi, Tatsuya Tada, Mari Tohya, et al.. (2022). Plasmids Harboring a Tandem Duplicate of bla VIM-24 in Carbapenem-Resistant ST1816 Pseudomonas aeruginosa in Japan. Microbial Drug Resistance. 29(1). 10–17. 1 indexed citations
6.
Tohya, Mari, Kanae Teramoto, Shin Watanabe, et al.. (2022). Whole-Genome Sequencing-Based Re-Identification of Pseudomonas putida / fluorescens Clinical Isolates Identified by Biochemical Bacterial Identification Systems. Microbiology Spectrum. 10(2). e0249121–e0249121. 11 indexed citations
7.
Tada, Tatsuya, Satoshi Oshiro, Tomomi Hishinuma, et al.. (2022). Modified Drug-Susceptibility Testing and Screening Culture Agar for Colistin-Susceptible Enterobacteriaceae Isolates Harboring a Mobilized Colistin Resistance Gene mcr-9. Journal of Clinical Microbiology. 60(12). e0139922–e0139922. 5 indexed citations
8.
9.
Tohya, Mari, et al.. (2022). Emergence of a highly colistin-resistant Aeromonas jandaei clinical isolate harbouring four genes encoding phosphoethanolamine transferases in Nepal. International Journal of Antimicrobial Agents. 59(4). 106544–106544. 3 indexed citations
10.
Takahashi, Toshihiro, Tatsuya Tada, Tomomi Hishinuma, et al.. (2021). Molecular characterisation of carbapenem-resistant Pseudomonas aeruginosa clinical isolates in Nepal. Journal of Global Antimicrobial Resistance. 26. 279–284. 20 indexed citations
11.
Tada, Tatsuya, Tomomi Hishinuma, Mari Tohya, et al.. (2020). Emergence of Carbapenem-Resistant Providencia rettgeri and Providencia stuartii Producing IMP-Type Metallo-β-Lactamase in Japan. Antimicrobial Agents and Chemotherapy. 64(11). 18 indexed citations
12.
Tada, Tatsuya, Hiroki Uchida, Tomomi Hishinuma, et al.. (2020). Highly multidrug-resistant Morganella morganii clinical isolates from Nepal co-producing NDM-type metallo-β-lactamases and the 16S rRNA methylase ArmA. Journal of Medical Microbiology. 69(4). 572–575. 6 indexed citations
13.
Hishinuma, Tomomi, et al.. (2020). Emergence and spread of VIM-type metallo-β-lactamase-producing Pseudomonas aeruginosa clinical isolates in Japan. Journal of Global Antimicrobial Resistance. 23. 265–268. 23 indexed citations
14.
Tada, Tatsuya, Hiroki Uchida, Tomomi Hishinuma, et al.. (2020). Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates from hospitals in Myanmar. Journal of Global Antimicrobial Resistance. 22. 122–125. 22 indexed citations
15.
Tada, Tatsuya, Hiroki Uchida, Tomomi Hishinuma, et al.. (2020). Emergence of clinical isolates of highly carbapenem-resistant Klebsiella pneumoniae co-harboring blaNDM-5 and blaOXA-181 or -232 in Nepal. International Journal of Infectious Diseases. 92. 247–252. 23 indexed citations
16.
Tada, Tatsuya, Jun‐ichiro Sekiguchi, Shin Watanabe, et al.. (2019). Assessment of a newly developed immunochromatographic assay for NDM-type metallo-β-lactamase producing Gram-negative pathogens in Myanmar. BMC Infectious Diseases. 19(1). 565–565. 13 indexed citations
17.
Hishinuma, Tomomi, Tatsuya Tada, Kyoko Kuwahara‐Arai, et al.. (2018). Spread of GES-5 carbapenemase-producing Pseudomonas aeruginosa clinical isolates in Japan due to clonal expansion of ST235. PLoS ONE. 13(11). e0207134–e0207134. 39 indexed citations
18.
Katayama, Yuki, et al.. (2016). Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus. Antimicrobial Agents and Chemotherapy. 60(6). 3730–3742. 51 indexed citations
19.
Hiramatsu, Keiichi, et al.. (2014). Vancomycin-intermediate resistance in Staphylococcus aureus. Journal of Global Antimicrobial Resistance. 2(4). 213–224. 71 indexed citations
20.
Shoji, Mitsutaka, Longzhu Cui, Hui‐min Neoh, et al.. (2011). walK and clpP Mutations Confer Reduced Vancomycin Susceptibility in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 55(8). 3870–3881. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shang Wei Wu Breakdown of academic impact, for papers by Choon Kim Breakdown of academic impact, for papers by Steve N. Leonard Breakdown of academic impact, for papers by Zhiwei Lin Breakdown of academic impact, for papers by Q. C. Truong-Bolduc Breakdown of academic impact, for papers by Sandra Rincón Breakdown of academic impact, for papers by Heidi Gumpert Breakdown of academic impact, for papers by Anthony J. Yeh Breakdown of academic impact, for papers by Emily K. Crispell Breakdown of academic impact, for papers by Feng-Jui Chen
Rankless by CCL
2026